PORDON, ELENA
PORDON, ELENA
Comparison of pulse versus conventional steroid treatment for hospitalized COVID-19 patients
2023-01-01 Cameli, P; Pianigiani, T; Guerrieri, M; Alonzi, V; Fabbri, G; Pordon, E; Messina, M; Ventura, V; Croce, S; Meocci, M; Perea, B; Perillo, F; Mezzasalma, F; Cekorja, B; Bargagli, E
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases
2023-01-01 Bergantini, Laura; D'Alessandro, Miriana; Cavallaro, Dalila; Pordon, Elena; Cassai, Lucia; Gangi, Sara; Meloni, Federica; Montagnani, Francesca; Paladini, Piero; Refini, Rosa Metella; Luzzi, Luca; Fossi, Antonella; Bargagli, Elena; Bennett, David
MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients
2023-01-01 Cameli, Paolo; Pordon, Elena; D’Alessandro, Miriana; Marzi, Maria Laura; Galasso, Lucrezia; Biuzzi, Cesare; Bergantini, Laura; Bargagli, Elena; Scolletta, Sabino; Franchi, Federico
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies
2023-01-01 Conticini, Edoardo; D'Alessandro, Miriana; Cameli, Paolo; Bergantini, Laura; Pordon, Elena; Cassai, Lucia; Cantarini, Luca; Bargagli, Elena; Frediani, Bruno; Porcelli, Brunetta
T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients
2023-01-01 Messina, M; D'Alessandro, M; Gangi, S; Bergantini, L; Mezzasalma, F; Viani, M; Guerrieri, M; Cassai, L; Pordon, E; Croce, S; Abbritti, M; Baglioni, S; Cameli, P; Bargagli, E
The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
2022-01-01 Cameli, Paolo; Alonzi, Valerio; D'Alessandro, Miriana; Bergantini, Laura; Pordon, Elena; Guerrieri, Marco; Refini, Rosa Metella; Sestini, Piersante; Bargagli, Elena
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Comparison of pulse versus conventional steroid treatment for hospitalized COVID-19 patients | 1-gen-2023 | Cameli, P; Pianigiani, T; Guerrieri, M; Alonzi, V; Fabbri, G; Pordon, E; Messina, M; Ventura, V; Croce, S; Meocci, M; Perea, B; Perillo, F; Mezzasalma, F; Cekorja, B; Bargagli, E | - | |
| Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases | 1-gen-2023 | Bergantini, Laura; D'Alessandro, Miriana; Cavallaro, Dalila; Pordon, Elena; Cassai, Lucia; Gangi, Sara; Meloni, Federica; Montagnani, Francesca; Paladini, Piero; Refini, Rosa Metella; Luzzi, Luca; Fossi, Antonella; Bargagli, Elena; Bennett, David | - | |
| MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients | 1-gen-2023 | Cameli, Paolo; Pordon, Elena; D’Alessandro, Miriana; Marzi, Maria Laura; Galasso, Lucrezia; Biuzzi, Cesare; Bergantini, Laura; Bargagli, Elena; Scolletta, Sabino; Franchi, Federico | - | |
| Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies | 1-gen-2023 | Conticini, Edoardo; D'Alessandro, Miriana; Cameli, Paolo; Bergantini, Laura; Pordon, Elena; Cassai, Lucia; Cantarini, Luca; Bargagli, Elena; Frediani, Bruno; Porcelli, Brunetta | - | |
| T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients | 1-gen-2023 | Messina, M; D'Alessandro, M; Gangi, S; Bergantini, L; Mezzasalma, F; Viani, M; Guerrieri, M; Cassai, L; Pordon, E; Croce, S; Abbritti, M; Baglioni, S; Cameli, P; Bargagli, E | - | |
| The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study | 1-gen-2022 | Cameli, Paolo; Alonzi, Valerio; D'Alessandro, Miriana; Bergantini, Laura; Pordon, Elena; Guerrieri, Marco; Refini, Rosa Metella; Sestini, Piersante; Bargagli, Elena | - |